- Home
- Media Center
- Press releases
- Innovative Medicine
Innovative Medicine
Janssen Connected Care Challenge Finalists Announced
Janssen Healthcare Innovation awards three finalists $50,000 each to advance solutions to deliver better care after hospital stays to improve patient outcomes
Therakos, Inc. Launches Lighting Up Lives Anniversary Campaign to Celebrate 25-Year Impact of Innovative Immune Modulation Therapy
Lighting Up Lives initiative debuts at ASFA and pays tribute to lives transformed by Extracorporeal Photopheresis (ECP) therapy
Charlie Wilson Teams Up With Janssen Biotech to Launch Making Awareness a Priority (M.A.P.)
Legendary R&B Musician and Prostate Cancer Survivor Lends His Voice to Build Prostate Cancer Awareness in the African-American Community
XARELTO® (rivaroxaban) Demonstrates Comparable Efficacy to Standard of Care for the Treatment and Secondary Prevention of Venous Blood Clots in Patients with Symptomatic Pulmonary Embolism in Pivotal Phase 3 Study
Rivaroxaban Showed Similar Safety Profile with Significantly Fewer Major Bleeds vs. Standard of Care Phase 3 Study Presented as Late-Breaker at the American College of Cardiology Annual Scientific Sessions and Published in the New England Journal of Medicine
Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer
Second ZYTIGA Phase 3 Study to be Unblinded, Based on Unanimous Recommendation of Independent Data Monitoring Committee
New Patient Guidebook, “Live Healthier – Weight Loss Options for Treating Obesity,” Now Offered by the American College of Physicians Foundation
Guidebook and DVD Help Patients Learn About Obesity and Available Treatment Options